Condition

Gastric/Gastroesophageal Junction Cancer

ClinicalTrials.gov condition label

Clinical trials3

Recruiting1

Common interventions4

Lead sponsors shown3

Clinical trials

3 shown

Study to Assess the Effect of OCT-598 in Patients With Advanced Solid TumorsNCT07358806 · 2025-12-18

RECRUITING

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid TumorsNCT07036185 · 2025-06-24

NOT_YET_RECRUITING

KN026 in Patients With HER2 Expressing Breast Cancer and Gastric CancerNCT03847168 · 2019-06-18

UNKNOWN

Common interventions

DocetaxelCOMBINATION_PRODUCT1KJ015 Injection (Subcutaneous Injection)DRUG1KN026DRUG1OCT-598DRUG1

Leading sponsors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd1Oscotec Inc.1Shanghai Bao Pharmaceuticals Co., Ltd.1

Trial status mix

NOT_YET_RECRUITING1

RECRUITING1

UNKNOWN1

Phase mix

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.